<DOC>
	<DOCNO>NCT02976441</DOCNO>
	<brief_summary>The investigator hypothesize study show sufficient lymphocyte stem cell harvest prior chemoradiation reinfused back treatment , least 5 10 patient ( 50 % ) achieve absolute increase lymphocyte count 300 cells/mm^3 four week stem cell reinfusion high grade glioma patient .</brief_summary>
	<brief_title>Autologous Stem Cell Collection Reinfusion Newly Diagnosed High Grade Gliomas</brief_title>
	<detailed_description />
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Astrocytoma</mesh_term>
	<mesh_term>Ependymoma</mesh_term>
	<mesh_term>Oligodendroglioma</mesh_term>
	<mesh_term>Optic Nerve Glioma</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>Histologically confirm newly diagnose high grade glioma pathology ( WHO grade III IV ) . At least 18 year age . Karnofsky performance status ≥ 60 % Normal bone marrow organ function define : Absolute neutrophil count ≥ 1,500/mcl Platelets ≥ 100,000/mcl Hematocrit ≥ 30 % Absolute lymphocyte count ≥ 1000/mcl Blood transfusion permit allow potential participant meet criterion . Postoperative treatment plan must include standard radiation temozolomide . Women childbearing potential men must agree use adequate contraception ( hormonal barrier method birth control , abstinence ) prior study entry duration study participation . Should woman become pregnant suspect pregnant participating study , must inform treat physician immediately . Ability understand willingness sign IRB approve write informed consent document ( legally authorize representative , applicable ) . Prior treatment radiation therapy , chemotherapy , immunotherapy , biologic agent ( include immunotoxins , immunoconjugates , antisense , peptide receptor antagonist , interferon , interleukin , TIL , LAK , gene therapy ) , hormonal therapy . Glucocorticoid therapy allow . AntiVEGF therapy within 6 week registration . A history malignancy ≤ 5 year previous exception basal cell squamous cell carcinoma skin treat local resection carcinoma situ cervix . Currently receive investigational agent might affect lymphocyte . Patients receive Novocure allow study . A history allergic reaction attribute compound similar chemical biologic composition filgrastim plerixafor agent use study . Fresh CNS bleed evident MRI CT. Contraindicated anticoagulation . Uncontrolled intercurrent illness include , limited , ongoing active infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , psychiatric illness/social situation would limit compliance study requirement . Pregnant and/or breastfeeding . Women childbearing potential must negative pregnancy test within 14 day study entry . Known HIVpositivity .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>